Technische Universität München (TUM)

Face2Face: Real-time face capture and reenactment of RGB videos (2019) Thies J, Zollhofer M, Stamminger M, Theobalt C, Niessner M Journal article Benefits from using mixed precision computations in the ELPA-AEO and ESSEX-II eigensolver projects (2019) Alvermann A, Basermann A, Bungartz HJ, Carbogno C, Ernst D, Fehske H, Futamura Y, et al. Journal article A homozygous splice site mutation in SLC25A42, encoding the mitochondrial transporter of coenzyme a, causes metabolic crises and epileptic encephalopathy (2019) Iuso A, Alhaddad B, Weigel C, Kotzaeridou U, Mastantuono E, Schwarzmayr T, Graf E, et al. Book chapter / Article in edited volumes A High-Calorie Diet Aggravates Mitochondrial Dysfunction and Triggers Severe Liver Damage in Wilson Disease Rats (2019) Einer C, Leitzinger C, Lichtmannegger J, Eberhagen C, Rieder T, Borchard S, Wimmer R, et al. Journal article Affective and behavioural computing: Lessons learnt from the First Computational Paralinguistics Challenge (2019) Schuller B, Weninger F, Zhang Y, Ringeval F, Batliner A, Steidl S, Eyben F, et al. Journal article, Review article Unmet medical needs in metastatic lung and digestive neuroendocrine neoplasms (2019) Capdevila J, Bodei L, Davies P, Gorbounova V, Jensen RT, Knigge UP, Krejs GJ, et al. Journal article Prevention of Cervical Cancer (2019) Hillemanns P, Friese K, Dannecker C, Klug S, Seifert U, Iftner T, Haedicke J, et al. Journal article, Review article Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab (2019) Eckstein M, Erben P, Kriegmair MC, Worst TS, Weiss CA, Wirtz RM, Wach S, et al. Journal article Loop Swapping as a Potent Approach to Increase Ene Reductase Activity with Nicotinamide Adenine Dinucleotide (NADH) (2019) Mähler C, Kratzl F, Vogel M, Vinnenberg S, Weuster-Botz D, Castiglione K Journal article, Original article Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis (2019) Fasching P, Hartkopf AD, Gaß P, Häberle L, Akpolat-Basci L, Hein A, Volz B, et al. Journal article